Year Item Type Full Text

2024

Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial. (2024) Kityo, Cissy; Mambule, Ivan K; Musaazi, Joseph; Sokhela, Simiso; Mugerwa, Henry; Ategeka, Gilbert; Cresswell, Fiona; Siika, Abraham; Kosgei, Josphat; Shah, Reena; Naidoo, Logashvari; Opiyo, Kimton; Otike, Caroline; Möller, Karlien; Kaimal, Arvind; Wambui, Charity; Van Eygen, Veerle; Mohammed, Perry; Addo Boateng, Fafa; Paton, Nicholas I; CARES trial team picture_as_pdf

2023

Recent advances in the treatment of tuberculosis. (2023) Motta, Ilaria; Boeree, Martin; Chesov, Dumitru; Dheda, Keertan; Günther, Gunar; Horsburgh, Charles Robert; Kherabi, Yousra; Lange, Christoph; Lienhardt, Christian; McIlleron, Helen M; Paton, Nicholas I; Stagg, Helen R; Thwaites, Guy; Udwadia, Zarir; Van Crevel, Reinout; Velásquez, Gustavo E; Wilkinson, Robert J; Guglielmetti, Lorenzo; Study group on Mycobacteria (ESGMYC) of the European Society of

Treatment Strategy for Rifampin-Susceptible Tuberculosis. (2023) Paton, Nicholas I; Cousins, Christopher; Suresh, Celina; Burhan, Erlina; Chew, Ka Lip; Dalay, Victoria B; Lu, Qingshu; Kusmiati, Tutik; Balanag, Vincent M; Lee, Shu Ling; Ruslami, Rovina; Pokharkar, Yogesh; Djaharuddin, Irawaty; Sugiri, Jani JR; Veto, Rholine S; Sekaggya-Wiltshire, Christine; Avihingsanon, Anchalee; Sarin, Rohit; Papineni, Padmasayee; Nunn, Andrew J; Crook, Angela M; TRUNCATE-TB Trial Team